
Veraxa Biotech fell 95.8% from $24.79 to $1.04, behind the S&P 500's −6.5%. Its worst day was Jun 16 (−56.7%), and its low came Nov 4 at $0.95.
Jun 11, 2026 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Veraxa Biotech shares fell 56.7%, while the S&P 500 fell 0.6%.
−56.7%, the year's worst day · S&P 500 −0.6%
Veraxa Biotech shares rose 38.4%, while the S&P 500 fell 0.5%.
+38.4%, the year's best day, on 6M shares, the year's heaviest volume · S&P 500 −0.5%
Story events cover the past 12 months · Times ET
Veraxa Biotech closed at its lowest level of the year, 96.2% below where the year started.
−4.0% · S&P 500 +1.7%
Where it ended: a close of $1.04 on Nov 20, 2026.
Nothing in the past 12 months.
All VRXA earningsNothing in the past 12 months.
All VRXA analyst actionsNothing in the past 12 months.
All VRXA dividend history